SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-025650
Filing Date
2024-08-09
Accepted
2024-08-09 08:01:37
Documents
19
Period of Report
2024-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240807_8k.htm   iXBRL 8-K 64735
2 EXHIBIT 3.1 ex_710634.htm EX-3.1 8390
3 EXHIBIT 99 ex_710324.htm EX-99.1 22511
4 EXHIBIT 99.2 ex_710672.htm EX-99.2 11104
9 ex_710324img002.jpg GRAPHIC 766
10 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-025650.txt   273977

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240809.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240809_def.xml EX-101.DEF 12567
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240809_lab.xml EX-101.LAB 16934
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240809_pre.xml EX-101.PRE 12892
21 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240807_8k_htm.xml XML 3164
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 241190454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)